A comparison of naloxegol versus alvimopan at the time of cystectomy and urinary diversion.

Author: BunnWeslyn, ChangYu-Hui H, DurantAdri M, FarajKassem S, MaulerDavid, TysonMark D

Paper Details 
Original Abstract of the Article :
The use of alvimopan at the time of cystectomy has been associated with improved perioperative outcomes. Naloxegol is a less costly alternative that has been used in some centers. This study aims to compare the perioperative outcomes of patients undergoing cystectomy with urinary diversion who recei...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://pubmed.ncbi.nlm.nih.gov/35969724

データ提供:米国国立医学図書館(NLM)

Naloxegol vs. Alvimopan: Comparing Two Mu-Opioid Antagonists in Cystectomy Patients

Cystectomy, a complex surgical procedure, often leads to postoperative complications, such as bowel dysfunction. This study investigates the use of two mu-opioid antagonists, naloxegol and alvimopan, in patients undergoing cystectomy. This research, like a careful comparison of different routes through a desert, explores the effectiveness of different approaches to managing this specific challenge.

Comparing Naloxegol and Alvimopan: A Quest for Improved Outcomes

This study aims to compare the perioperative outcomes of patients receiving naloxegol versus alvimopan, highlighting the potential benefits of each drug in managing bowel dysfunction after cystectomy. This research, much like a desert traveler seeking the most efficient path, explores the effectiveness of different strategies for achieving the best possible outcomes.

Comparing Naloxegol and Alvimopan: A Quest for Improved Outcomes

This study offers valuable insights for healthcare providers, helping them make informed decisions about the use of mu-opioid antagonists in cystectomy patients. This research, like a detailed map of the desert, provides critical information for navigating the complex terrain of postoperative management.

Dr.Camel's Conclusion

This study investigates the effectiveness of naloxegol and alvimopan in managing bowel dysfunction after cystectomy. This research, like a camel caravan carefully considering different paths through a desert, explores the potential benefits of different approaches to managing this specific challenge.

Date :
  1. Date Completed 2022-08-17
  2. Date Revised 2022-09-01
Further Info :

Pubmed ID

35969724

DOI: Digital Object Identifier

35969724

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.